Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Trading Update

13 Jul 2016 07:00

RNS Number : 9463D
Fenner PLC
13 July 2016
 

13 July 2016

Fenner PLC("Fenner" or "the Group")

Trading update

Fenner is providing its customary trading update covering the period from 1 March to 12 July 2016.

The trading results for the third quarter have reflected further improvements in line with our plans.

This performance is against the backdrop of our principal markets having shown no recovery and, in some cases, having deteriorated further. In response to these conditions, the Group has succeeded in achieving further benefits from operational efficiencies and market share gains.

Business review

AEP's medical businesses have continued to perform well and the Secant relocation programme is now entering the testing and certification phase. Although the industrial businesses are seeing some fragility in their wider markets, new product initiatives are offsetting these effects.

Whilst the recent small increase in the US rig count, combined with market share gains, is expected to benefit our oil/gas businesses, given lead times, the effect of this is most likely to be felt in the new financial year.

In the Northern Hemisphere, ECS's industrial businesses have remained stable whilst the US coal industry continues to be challenging. The refocussing of our North American business remains on track.

In Australia, ECS's operational improvements have mitigated on-going pricing pressures from customers in the mining industry.

Financing review

Cash flow during the period has reflected normal seasonality and has remained within the range of the Group's expectations. However, due to the recent significant deterioration in the value of sterling against the US dollar, the Group's net debt at the year-end is likely to be above previous expectations, entirely due to currency translation.

The depreciation of sterling will also benefit the translation of the Group's overseas earnings albeit that, given the timing, the impact in the current financial year will be marginal. In any event, the underlying net debt to EBITDA ratio, as measured by the Group's lenders using constant currencies, will not be significantly impacted.

Outlook

The Board expects that the Group will achieve an overall outcome for the financial year ending 31 August 2016 in line with previous expectations, save for the small currency related increase in earnings referenced above.

 

For further information please contact:

Fenner PLC

Mark Abrahams, Chief Executive OfficerJohn Pratt, Group Finance Director

01482 62650001482 626500

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Important notice

Certain statements contained herein constitute forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors which may cause the actual results, performance or achievements of Fenner, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such statements. Such risks, uncertainties and other factors include, among others, exchange rates, the commodity markets, general economic conditions and the business environment.

Notes to editors:

Fenner is a world leader in reinforced polymer technology, providing local engineered solutions for performance‐critical applications. The Group operates through two divisions:

Advanced Engineered Products: the AEP division uses advanced polymeric materials and technical expertise to provide high value-added solutions to customers' most challenging engineering problems. Customers are spread across a variety of end‐user segments, including oil & gas, medical, construction, transportation, automation and general industrial. AEP's trading names are recognised globally and include CDI Energy Products, EGC Critical Components, Hallite, AIP Precision Machining, Fenner Precision, Fenner Drives, James Dawson, Mandals, Secant Medical, Charter Medical and Xeridiem.

Engineered Conveyor Solutions: the ECS division, trading under the Fenner Dunlop, Fenner and Dunlop brand names, is a recognised leader in the global conveying market. The division offers a unique, comprehensive suite of products and services, which serve the conveying needs of mining, power generation and bulk handling markets. ECS is managed on the basis of two regional business groupings being ECS Southern Hemisphere (comprising Australia, RSA and China, where the customer base is focused on mining) and ECS Northern Hemisphere (including the Americas and Europe, where there is a larger exposure to industrial customers).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFIIDRIFLIR
Date   Source Headline
28th Oct 20154:16 pmRNSHolding(s) in Company
22nd Oct 20159:41 amRNSHolding(s) in Company
19th Oct 20152:36 pmRNSHolding(s) in Company
7th Oct 20159:20 amRNSHolding(s) in Company
10th Sep 20153:34 pmRNSHolding(s) in Company
10th Sep 201511:49 amRNSHolding(s) in Company - Amendment
9th Sep 20154:02 pmRNSHolding(s) in Company
9th Sep 20151:24 pmRNSHolding(s) in Company
8th Sep 20157:00 amRNSPre-Close Trading Statement
4th Sep 20153:06 pmRNSHolding(s) in Company
2nd Sep 20151:13 pmRNSHolding(s) in Company
2nd Sep 20159:34 amRNSBlocklisting Interim Review
24th Jul 201511:11 amRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Update
6th Jul 201510:16 amRNSHolding(s) in Company
17th Jun 20154:39 pmRNSHolding(s) in Company
28th Apr 201511:09 amRNSHolding(s) in Company
22nd Apr 20157:00 amRNSHalf Yearly Report
20th Apr 20153:53 pmRNSHolding(s) in Company
10th Apr 20152:21 pmRNSHolding(s) in Company
8th Apr 20152:37 pmRNSHolding(s) in Company
2nd Apr 20159:37 amRNSHolding(s) in Company
25th Mar 20154:07 pmRNSHolding(s) in Company
20th Mar 20158:46 amRNSHolding(s) in Company
19th Mar 20151:31 pmRNSHolding(s) in Company
12th Mar 20157:00 amRNSPre-Close Trading Statement
2nd Mar 201511:23 amRNSBlocklisting Interim Review
2nd Feb 20157:00 amRNSAcquisition
30th Jan 20153:54 pmRNSDirector/PDMR Shareholding
29th Jan 20151:24 pmRNSDirector/PDMR Shareholding
21st Jan 201511:10 amRNSDirectorate Change
21st Jan 201511:08 amRNSDirector Declaration
15th Jan 201512:09 pmRNSResult of AGM
14th Jan 20157:00 amRNSAGM Trading Update
1st Dec 201411:44 amRNSDirector/PDMR Shareholding
21st Nov 20141:03 pmRNSDirector/PDMR Shareholding
21st Nov 201411:36 amRNSDirector/PDMR Shareholding
21st Nov 201411:27 amRNSDirector/PDMR Shareholding
20th Nov 20143:34 pmRNSDirector/PDMR Shareholding
18th Nov 201410:46 amRNSDirector/PDMR Shareholding
12th Nov 201410:01 amRNSDirector/PDMR Shareholding
11th Nov 20147:00 amRNSFinal Results
6th Nov 201410:03 amRNSHolding(s) in Company
5th Nov 20142:38 pmRNSHolding(s) in Company
23rd Sep 20149:26 amRNSHolding(s) in Company
9th Sep 20147:00 amRNSPre-Close Trading Statement
2nd Sep 20144:04 pmRNSTotal Voting Rights
2nd Sep 20142:57 pmRNSDirector/PDMR Shareholding
2nd Sep 20142:44 pmRNSBlocklisting Interim Review
27th Aug 20149:38 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.